Home » TEVA REPORTS RECORD 1Q COPAXONE SALES
TEVA REPORTS RECORD 1Q COPAXONE SALES
Drug
maker Teva Pharmaceutical Industries Ltd. said Friday that sales of its multiple
sclerosis drug Copaxone hit record levels in advance of its first-quarter earnings
announcement.
Business
Week
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May